“Circulating Tumour DNA for Minimal Residual Disease: Assay Sensitivity and the Decisions It Cannot Yet Support”. 2023. Translational Medicine & Therapeutics Journal 2 (2): 110-19. https://doi.org/10.5281/zenodo.22649122.